Stock Groups

U.S. to donate an additional 500 million COVID-19 vaccines By Reuters


© Reuters. FILEPHOTO: Pfizer BioNTech Coronavirus Disease (COVID-19), is prepared by a nurse as part of the vaccine drive of the Fernandeno Tataviam Band of Mission Indians. Arleta, Los Angeles. U.S.A, August 23rd, 2021. REUTERS/Lucy Nicholson

By Jeff Mason

WASHINGTON (Reuters) -The United States plans to donate an additional 500 million COVID-19 vaccines made by Pfizer Inc (NYSE:) and BioNTech SE (NASDAQ:) to nations around the world, lifting the total the country is sharing to more than 1 billion doses, according to a source familiar with the plans.

The new promise will be made by President Joe Biden at a virtual summit regarding COVID-19.

Biden stated earlier on Tuesday that more than $15B had been contributed by the United States to the international response to COVID-19 to help fund over 160 million COVID-19 vaccinations across the globe.

Already, the United States had purchased more than 500,000 doses from BioNTech/Pfizer and donated them via the COVAX global vaccine-sharing platform.

Biden stated that vaccines have already reached 100 countries and that he will announce further commitments Wednesday at the U.S. hosted global COVID-19 summit.

A draft U.S. document viewed and approved by Reuters shows that the United States has asked global leaders for their support in achieving its COVID-19 goals, which include ensuring vaccine coverage of 70% by 2022.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. Instead, they are determined by marketmakers. As such, the prices might not reflect market conditions and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



Mike Robinson
Mike covers the financial, utilities and biotechnology sectors for Street Register. He has been writing about investment and personal finance topics for almost 12 years. Mike has an MBA in Finance from Wake Forest University.